What is Gene By Gene?
Gene By Gene operates at the intersection of genomics and clinical informatics, providing a sophisticated Clinical Reporting Application designed to mitigate the complexities inherent in laboratory data management. By bridging the gap between raw analytical output and actionable clinical insights, the platform serves as a critical infrastructure layer for healthcare providers. The solution integrates seamlessly with electronic lab ordering systems, facilitating secure, HIPAA-compliant distribution of patient results. Through its focus on productivity enhancement and cost reduction, Gene By Gene addresses the systemic inefficiencies that currently plague modern diagnostic practices, positioning itself as an essential partner for clinical laboratories seeking to scale their operations while maintaining rigorous data integrity standards.
How much funding has Gene By Gene raised?
Gene By Gene has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Gene By Gene
PPP
Public-Private Partnership
What's next for Gene By Gene?
With the recent influx of capital, Gene By Gene is poised to transition into a phase of aggressive market expansion and product refinement. The strategic roadmap likely involves deepening the integration capabilities of its cloud-based dashboard, thereby increasing the interoperability of its reporting suite across diverse electronic health record systems. As the healthcare sector continues to prioritize digital transformation, the company is strategically aligned to capture significant market share by offering a robust, scalable alternative to legacy reporting frameworks. Future growth will likely be driven by the expansion of its user base among large-scale clinical networks, further cementing its role as a foundational technology provider in the evolving landscape of precision medicine and diagnostic informatics.
See full Gene By Gene company page
